NO167381C - Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin.

Info

Publication number
NO167381C
NO167381C NO882655A NO882655A NO167381C NO 167381 C NO167381 C NO 167381C NO 882655 A NO882655 A NO 882655A NO 882655 A NO882655 A NO 882655A NO 167381 C NO167381 C NO 167381C
Authority
NO
Norway
Prior art keywords
fluorallylamine
fluorphenethyl
preparation
therapeutic active
analogue procedure
Prior art date
Application number
NO882655A
Other languages
English (en)
Other versions
NO882655L (no
NO882655D0 (no
NO167381B (no
Inventor
Ian A Mcdonald
Michael G Palfreyman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO882655D0 publication Critical patent/NO882655D0/no
Publication of NO882655L publication Critical patent/NO882655L/no
Publication of NO167381B publication Critical patent/NO167381B/no
Publication of NO167381C publication Critical patent/NO167381C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO882655A 1987-06-16 1988-06-15 Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin. NO167381C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6275887A 1987-06-16 1987-06-16

Publications (4)

Publication Number Publication Date
NO882655D0 NO882655D0 (no) 1988-06-15
NO882655L NO882655L (no) 1988-12-19
NO167381B NO167381B (no) 1991-07-22
NO167381C true NO167381C (no) 1991-10-30

Family

ID=22044602

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882655A NO167381C (no) 1987-06-16 1988-06-15 Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin.

Country Status (16)

Country Link
EP (1) EP0295604A1 (no)
JP (1) JP2511293B2 (no)
KR (1) KR970000142B1 (no)
CN (1) CN1031075A (no)
AR (1) AR243493A1 (no)
AU (1) AU612655B2 (no)
CA (1) CA1335897C (no)
DK (1) DK325788A (no)
FI (1) FI90658C (no)
HU (1) HU202823B (no)
IL (1) IL86746A0 (no)
NO (1) NO167381C (no)
NZ (1) NZ224982A (no)
PH (1) PH24012A (no)
PT (1) PT87732B (no)
ZA (1) ZA884183B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023023A1 (en) * 1992-05-15 1993-11-25 University Of Saskatchewan Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis
ATE147978T1 (de) * 1992-05-27 1997-02-15 Merrell Pharma Inc Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
US5599986A (en) * 1994-09-29 1997-02-04 Hoechst Marion Roussel Inc. Process for the preparation of alkali metal salts of diformylamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors
EP0224924B1 (en) * 1985-12-05 1992-01-22 Merrell Dow Pharmaceuticals Inc. Non-aromatic fluorallylamine mao inhibitors

Also Published As

Publication number Publication date
AR243493A1 (es) 1993-08-31
ZA884183B (en) 1989-02-22
PT87732B (pt) 1992-10-30
CN1031075A (zh) 1989-02-15
NO882655L (no) 1988-12-19
NO882655D0 (no) 1988-06-15
AU612655B2 (en) 1991-07-18
FI90658C (fi) 1994-03-10
CA1335897C (en) 1995-06-13
NZ224982A (en) 1990-08-28
PH24012A (en) 1990-02-09
DK325788D0 (da) 1988-06-15
FI882836A0 (fi) 1988-06-14
PT87732A (pt) 1988-07-01
IL86746A0 (en) 1988-11-30
KR890000399A (ko) 1989-03-14
EP0295604A1 (en) 1988-12-21
DK325788A (da) 1988-12-17
JP2511293B2 (ja) 1996-06-26
FI882836A (fi) 1988-12-17
AU1762988A (en) 1988-12-22
NO167381B (no) 1991-07-22
HUT51232A (en) 1990-04-28
HU202823B (en) 1991-04-29
FI90658B (fi) 1993-11-30
JPS6416752A (en) 1989-01-20
KR970000142B1 (ko) 1997-01-04

Similar Documents

Publication Publication Date Title
NO166232C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansyrer.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO884154L (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO883750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO884176L (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO167146C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO167381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv (e)-2-(p-fluorfenethyl)-3-fluorallylamin.
NO167144C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv imidazo (4,5-f) isokinolin-2-on.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.
NO160136C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av benzoylfenylpiperidin.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2000